Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
Carol J. Swallow(Princess Margaret Cancer Centre), Dimitri Tzanis(Université Paris Sciences et Lettres), Dario Callegaro(Fondazione IRCCS Istituto Nazionale dei Tumori), Hayden Snow(Peter MacCallum Cancer Centre), Myles Smith(Royal Marsden NHS Foundation Trust), Marco Fiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Anant Desai(NIHR Surgical Reconstruction and Microbiology Research Centre), Thomas F. DeLaney, Samuel Ford(NIHR Surgical Reconstruction and Microbiology Research Centre), Toufik Bouhadiba(Institut Curie), Kenneth Cardona(Emory University), Rebecca A. Gladdy(Lunenfeld-Tanenbaum Research Institute), Rick L. Haas(Leiden University), John E. Mullinax(Moffitt Cancer Center), Deanna Ng(Mount Sinai Hospital), Robin L. Jones(Seattle Cancer Care Alliance), Chandrajit P. Raut(Brigham and Women's Hospital), Sylvie Bonvalot(Institut Curie), Carolyn Nessim(University of Ottawa), D. Strauß(Royal Marsden Hospital), Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Gronchi(University of Milan), Winan J. van Houdt(Diakonessenhuis hospital), Markus Albertsmeier(Ludwig-Maximilians-Universität München), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Mark Fairweather(Brigham and Women's Hospital), Jae Berm Park(Samsung Medical Center), Christina L. Roland(The University of Texas MD Anderson Cancer Center), Eberhard Stoeckle(Institut Bergonié), Andrew Hayes(Royal Marsden NHS Foundation Trust), Ricardo González(Moffitt Cancer Center), David Gyorki(The University of Melbourne), Jacek Skoczylas(The Maria Sklodowska-Curie National Research Institute of Oncology)
Cited by 243
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k